Quantitative real time PCR for distinction between Pneumocystis jirovecii infection/colonization in hospitalized patients
Open Access
- 24 September 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1426200
Abstract
Background: Identification of the opportunistic fungus Pneumocystis jirovecii in respiratory specimens presents challenges, particularly in differentiating between colonization and active infection. The present study assessed a probe-based real time PCR (qPCR) diagnostic effectiveness in patients with diverse underlying conditions, particularly those with COVID-19 and pulmonary insufficiency.Methods: To set up the qPCR, clinical samples from 281 patients with respiratory ailments were tested. Subsequently, a descriptive study was conducted on 112 patients with pulmonary insufficiency with and without COVID-19 suspected of P. jirovecii infection. All specimens were subjected to DNA extraction followed by nested PCR and qPCR targeting the mitochondrial large subunit (mtLSU)-rRNA gene.Results: Based on nested PCR and qPCR, P. jirovecii was identified in 40 out of 281 patients, with slight variations in positive samples observed across dilutions. Three patients who tested positive in nested PCR yielded negative results in probe-based qPCR. Conversely, three patients who tested positive in probe-based qPCR yielded negative results in nested PCR. Considering nested PCR as the golden standard, probe-based qPCR demonstrated good diagnostic performance, with 92.5% sensitivity and 98.7% specificity. Based on cycle threshold (Ct) values, the positive cases were categorized: ≤32 as infection, >35 as colonization, and a grey zone between these values (32 < X ≤ 35). The analysis of 112 PCP-suspected patients revealed a prevalence ranging from 6.25% (nested PCR) to 7% (probe-based qPCR).Conclusions: This study suggested Ct values to differentiate Pneumocystis pneumonia/colonization in immunocompromised patients. To further augment the diagnostic sensitivity, it is recommended to integrate qPCR results with clinical parameters and biomarkers to offer a more precise understanding of Pneumocystis-related conditions.Keywords
This publication has 31 references indexed in Scilit:
- Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfallsCurrent Opinion in Infectious Diseases, 2021
- The presence of Pneumocystis jirovecii in critically ill patients with COVID-19Journal of Infection, 2021
- Diagnosis of Pneumocystis pneumonia by real-time PCR in patients with various underlying diseasesJournal of Microbiology, Immunology and Infection, 2020
- Pneumocystis Jirovecii detection and comparison of multiple diagnostic methods with quantitative real-time PCR in patients with respiratory symptomsSaudi Journal of Biological Sciences, 2020
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Pneumocystis jirovecii Pneumonia: Epidemiology, Clinical Manifestation and DiagnosisCurrent Fungal Infection Reports, 2019
- Molecular diagnosis of Pneumocystis pneumonia in immunocompromised patientsCurrent Opinion in Infectious Diseases, 2019
- Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative PatientsThe American Journal of Medicine, 2014
- Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological featuresJournal of Infection and Chemotherapy, 2007
- A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluidDiagnostic Microbiology and Infectious Disease, 2006